探索总炎症血管体积作为巨细胞动脉炎诊断和预后生物标志物
本研究基于TOPAZIO研究的回顾性分析,纳入18例活动性大血管型巨细胞动脉炎(LV-GCA)患者共61次PET/CT扫描,评估总炎症血管体积(TIVV)与疾病活动及预后的关联。结果显示TIVV和总炎症糖酵解体积(TIGV)与活动性疾病强烈相关(OR分别为4.74和5.45),并与复发或主动脉扩张时间强烈相关(HR分别为2.50和2.23),优于传统PET参数。
要点
- TIVV与活动性疾病相关OR 4.74(95%CI 1.23-18.2),TIGV OR 5.45(95%CI 1.36-21.8)。
- TIVV与复发或主动脉扩张时间相关HR 2.50(95%CI 1.07-5.84),TIGV HR 2.23(95%CI 1.04-4.82)。
- PETVAS和TVS与活动性疾病及预后的关联较弱。
核心结论
- TIVV和TIGV在诊断和预后性能上优于传统PET参数,凸显炎症体积在评估LV-GCA疾病活动中的重要性。
研究设计与样本
- 回顾性分析TOPAZIO研究中的PET/CT扫描,纳入活动性LV-GCA患者,接受托珠单抗单药治疗52周,此前给予三次静脉甲泼尼龙冲击。
- 共纳入18例患者,合计61次PET/CT扫描,扫描时间点为基线及第24、52、78周。
主要发现
- TIVV与活动性疾病相关OR 4.74(95%CI 1.23-18.2),TIGV OR 5.45(95%CI 1.36-21.8)。
- PETVAS与活动性疾病相关OR 2.16(95%CI 0.87-5.33),TVS OR 1.86(95%CI 0.76-4.52)。
- 中位随访117周期间发生10例事件,TIVV与复发或主动脉扩张时间相关HR 2.50(95%CI 1.07-5.84),TIGV HR 2.23(95%CI 1.04-4.82)。
- PETVAS和TVS与预后的关联较弱。
关键数值与推荐
- TIVV通过半自动方法计算,TIGV为TIVV乘以平均标准化摄取值(SUVmean)。
- 视觉评估后计算PET血管活动评分(PETVAS)和总血管评分(TVS)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objectives of this study were to investigate the role of total inflammation vascular volume (TIVV), a novel quantitative parameter obtained from 18-fluorodeoxyglucose (18F-FDG) PET/CT, in assessing disease activity and predicting relapses and aortic dilatation in patients with large-vessel (LV)-GCA. METHODS: This retrospective analysis included PET/CT scans from the TOPAZIO study. Patients with active LV-GCA were enrolled and treated with tocilizumab monotherapy for 52 weeks, preceded by three boluses of i.v. methylprednisone. PET/CT scans were performed at baseline and at weeks 24, 52 and 78. TIVV was calculated using a semiautomatic approach, while total inflammation glycolytic volume (TIGV) was obtained by multiplying TIVV by the mean standardized uptake value (SUVmean). Visual assessment was performed, and PET vascular activity score (PETVAS) and total vascular score (TVS) were calculated. RESULTS: Eighteen patients with a total of 61 PET scans were included. TIVV and TIGV were strongly associated with active disease, with odds ratios (ORs) of 4.74 (95% CI 1.23-18.2) and 5.45 (95% CI 1.36-21.8), respectively, whereas PETVAS and TVS showed moderate associations (OR 2.16; 95% CI 0.87-5.33 and 1.86; 95% CI 0.76-4.52, respectively). Over a median follow-up of 117 weeks, 10 events occurred. The Cox proportional hazard model showed strong associations of TIVV and TIGV with time to relapse or aortic dilatation, with hazard ratios (HRs) of 2.50 (95% CI 1.07-5.84) and 2.23 (95% CI 1.04-4.82), respectively. PETVAS and TVS exhibited a weaker association with prognosis. CONCLUSION: TIVV and TIGV showed superior diagnostic and prognostic performance compared with conventional PET parameters, underscoring the importance of inflammation volume in evaluating disease activity in LV-GCA. TRIAL REGISTRATION: ClinicalTrials.gov, http://clinicaltrials.gov, NCT05394909.
引用
- Durmo R, Muratore F, Marvisi C, et al. Exploring total inflammatory vascular volume as a diagnostic and prognostic biomarker in giant cell arteritis. Rheumatology (Oxford). 2025. PMID: 40650989. doi:10.1093/rheumatology/keaf381
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。